Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin to Augment Resistance Training in Older Adults
NCT02308228Phase 1Completed
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Sarcopenia comparing Metformin with Placebo (2 arms). Primary endpoint: Percent Change in Type 2 Myofiber Cross Sectional Area at 16 weeks. Started Jan 2015; status: completed.
02
Drugs
metformin
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT02308228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02308228.